Floatz logo

(1-BENZYL-3-(ISOBUTYL-(4-NITRO-BENZENESULFONYL)-AMINO)-2-PHOSPHONOOXY-PROPYL)-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER

HIV Infection

Felizarta, Franco, M.D.Small moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

23 Active assets in the HIV Infection cohort.

Asset / SponsorPhaseRating
Lamivudine
José Antonio Mata Marín
Phase 4BBB
ETOPOSIDE
AIDS Malignancy Consortium
Phase 2BBB
Metformin
Brigham and Women's Hospital
Phase 4BB
Cyclophosphamide
AIDS Malignancy Consortium
Phase 3BB
PREDNISONE TABLETS
City of Hope Medical Center
Phase 2BB

View all 50 →

Same molecule, other indications

(1-BENZYL-3-(ISOBUTYL-(4-NITRO-BENZENESULFONYL)-AMINO)-2-PHOSPHONOOXY-PROPYL)-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER is also rated in:

HypertriglyceridemiaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →